Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JADE
NCT06769048Phase 2Active, not recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of BI 1584862 in geographic atrophy (GA), sponsored by Boehringer Ingelheim. Started Jan 2025; status: active, not recruiting.
02
Drugs
BI 1584862
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT06769048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06769048.